LANDOS BIOPHARMA INC
COM NEW · CUSIP 515069201
9
institutional holders
1.5m
shares reported held*
$6.3mreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $4.21.
Biggest buyers
| PERCEPTIVE ADVISORS LLC | New | +1.5m |
| Tower Research Capital LLC (TRC) | New | +1.5k |
| ROYAL BANK OF CANADA | New | +612 |
| ACADIAN ASSET MANAGEMENT LLC | New | +134 |
| JPMORGAN CHASE & CO | New | +59 |
| BlackRock Inc. | New | +42 |
| UBS Group AG | New | +37 |
| WELLS FARGO & COMPANY/MN | New | +9 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | New | 0 |
Biggest sellers
| None |
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| PERCEPTIVE ADVISORS LLC 0.18% of their portfolio | 1.5m $6.3m | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 1.5k $6.5k | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 612 $3.0k | New |
| ACADIAN ASSET MANAGEMENT LLC 0.00% of their portfolio | 134 $0 | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 59 $247 | New |
| BlackRock Inc. 0.00% of their portfolio | 42 $177 | New |
| UBS Group AG 0.00% of their portfolio | 37 $156 | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 9 $38 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | New |